Một nghiên cứu trên bệnh nhân mắc bệnh phổi kẽ (ILD) liên quan đến CTD
advertisement
App Information
Phiên bản
Cập nhật
02 th 08, 2024
Nhà phát triển
Thể loại
Google Play ID
Lượt cài đặt
100+
App Description
This app has been exclusively created for participants in the medical study for GSK BE-conneCTD ILD 221672. It contains Televisit functionality and allows participants to complete questionnaires.
A Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with interstitial lung disease (ILD) associated with connected tissue disease (CTD).
A Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with interstitial lung disease (ILD) associated with connected tissue disease (CTD).
Đọc thêm